WebCytoAgents, Inc 1,122 followers 11h Report this post Report Report. Back ... WebMar 10, 2024 · CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine ...
CytoAgents - Overview, News & Competitors
WebApr 28, 2024 · The partnership will focus on utilizing Quotient’s integrated service portfolio to support the rapid development of CytoAgents’ lead COVID-19 drug candidate, GP1681, for Phase I and II in 2024. Scientific consensus is building that severe illness caused by COVID-19 and other infectious diseases is triggered by a phenomenon known as ... WebSep 7, 2024 · PITTSBURGH--(BUSINESS WIRE)-- CytoAgents, Inc., a clinical-stage therapeutics company developing a safe, effective treatment (CTO1681) for Cytokine Release Syndrome (CRS), today announced that it has strengthened its leadership team with the appointment of Arthur P. Bertolino MD, PhD, MBA, as Chief Medical Officer.Dr. … how far is rhode island from maine
Preclinical development of an immunomodulatory agent capable …
WebNov 10, 2024 · September 07, 2024. CytoAgents Announces Appointment of New Chief Medical Officer. Addition of Arthur P. Bertolino Brings World Class Capabilities to Leadership Team, Positions CytoAgents for Phase 1b/2a Clinical Trials and Strategic Pharma Partnerships to Treat Cytokine Release Syndrome. Media Coverage. February 04, 2024. WebCytoAgents is a biotechnology company focused on the development of innovative pharmaceutical products for the treatment of COVID-19, Influenza, and other viral infectious diseases. Use the CB Insights Platform to explore CytoAgents's full profile. WebAbout GENCO Systems. GENCO Systems, Inc. was established in 1994 to provide the Federal Government and industry with superior professional services in engineering and … high buttock pain